Correlation Between Akari Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and CytomX Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and CytomX Therapeutics.
Diversification Opportunities for Akari Therapeutics and CytomX Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akari and CytomX is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the CytomX Therapeutics. In addition to that, Akari Therapeutics is 2.45 times more volatile than CytomX Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 101.00 in CytomX Therapeutics on August 29, 2024 and sell it today you would earn a total of 1.00 from holding CytomX Therapeutics or generate 0.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. CytomX Therapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| CytomX Therapeutics |
Akari Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite Akari Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |